Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.8M
-
Number of holders
-
226
-
Total 13F shares, excl. options
-
32.9M
-
Shares change
-
+2.36M
-
Total reported value, excl. options
-
$1.98B
-
Value change
-
+$144M
-
Put/Call ratio
-
0.22
-
Number of buys
-
122
-
Number of sells
-
-98
-
Price
-
$60.17
Significant Holders of RxSight, Inc. - Common Stock, $0.001 par value per share (RXST) as of Q2 2024
252 filings reported holding RXST - RxSight, Inc. - Common Stock, $0.001 par value per share as of Q2 2024.
RxSight, Inc. - Common Stock, $0.001 par value per share (RXST) has 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.9M shares
of 43.8M outstanding shares and own 75.23% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (3.69M shares), BlackRock Inc. (2.4M shares), VANGUARD GROUP INC (2.01M shares), LORD, ABBETT & CO. LLC (1.74M shares), Artisan Partners Limited Partnership (1.33M shares), FMR LLC (1.25M shares), MORGAN STANLEY (1.12M shares), Invesco Ltd. (1.05M shares), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (814K shares), and DEUTSCHE BANK AG\ (798K shares).
This table shows the top 226 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.